These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3315514)

  • 1. Long-term use of intranasal insulin in insulin-dependent diabetic patients.
    Frauman AG; Cooper ME; Parsons BJ; Jerums G; Louis WJ
    Diabetes Care; 1987; 10(5):573-8. PubMed ID: 3315514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of basal hepatic glucose production and fasting hyperglycemia of type I diabetic patients treated with human recombinant ultralente insulin.
    Riccio A; Avogaro A; Valerio A; Zappella A; Tiengo A; Del Prato S
    Diabetes Care; 1994 Jun; 17(6):535-40. PubMed ID: 8082521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term use of intramuscular insulin therapy in a type I diabetic patient with subcutaneous insulin resistance.
    Brossard JH; Havrankova J; Rioux D; Bertrand S; D'Amour P
    Diabet Med; 1993 Mar; 10(2):174-6. PubMed ID: 8458196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of early-morning hyperglycemia in IDDM patients with long-acting zinc insulin.
    Parillo M; Mura A; Iovine C; Rivellese AA; Lavicoli M; Riccardi G
    Diabetes Care; 1992 Feb; 15(2):173-7. PubMed ID: 1547673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal aerosolized insulin. Mixed-meal studies and long-term use in type I diabetes.
    Salzman R; Manson JE; Griffing GT; Kimmerle R; Ruderman N; McCall A; Stoltz EI; Mullin C; Small D; Armstrong J
    N Engl J Med; 1985 Apr; 312(17):1078-84. PubMed ID: 3885035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six month administration of gelified intranasal insulin in 16 type 1 diabetic patients under multiple injections: efficacy vs subcutaneous injections and local tolerance.
    Lalej-Bennis D; Boillot J; Bardin C; Zirinis P; Coste A; Escudier E; Chast F; Peynegre R; Slama G; Selam JL
    Diabetes Metab; 2001 Jun; 27(3):372-7. PubMed ID: 11431603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.
    Lepore M; Pampanelli S; Fanelli C; Porcellati F; Bartocci L; Di Vincenzo A; Cordoni C; Costa E; Brunetti P; Bolli GB
    Diabetes; 2000 Dec; 49(12):2142-8. PubMed ID: 11118018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early morning glycaemia and the metabolic consequences of delaying breakfast/morning insulin. A comparison of continuous subcutaneous insulin infusion and multiple injection therapy with human isophane or human ultralente insulin at bedtime in insulin-dependent diabetics.
    Haakens K; Hanssen KF; Dahl-Jørgensen K; Vaaler S; Torjesen P; Try K
    Scand J Clin Lab Invest; 1989 Nov; 49(7):653-9. PubMed ID: 2692136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.
    Burge MR; Waters DL; Holcombe JH; Schade DS
    J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of meal carbohydrate content on insulin requirements in type 1 diabetic patients treated intensively with the basal-bolus (ultralente-regular) insulin regimen.
    Rabasa-Lhoret R; Garon J; Langelier H; Poisson D; Chiasson JL
    Diabetes Care; 1999 May; 22(5):667-73. PubMed ID: 10332663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of beef ultralente for basal insulin delivery: plasma insulin concentrations after chronic ultralente administration in patients with IDDM.
    Rizza RA; O'Brien PC; Service FJ
    Diabetes Care; 1986; 9(2):120-3. PubMed ID: 3698778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultralente based insulin regimens--clinical applications, advantages and disadvantages.
    Turner RC; Phillips MA; Ward EA
    Acta Med Scand Suppl; 1983; 671():75-86. PubMed ID: 6349269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixtures of human intermediate and human regular insulin in type 1 diabetic patients. Evaluation of free insulin levels and insulin action on glucose metabolism after combined and separate subcutaneous administration.
    Klauser R; Schernthaner G; Prager R
    Diabetes Res Clin Pract; 1988 Sep; 5(3):185-90. PubMed ID: 3065016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cartridge insulin Penmix 50:50/Isophane with soluble/Isophane in type I diabetic adolescents using a multiple injection regimen.
    Wheeler KA; Ahmed ML; Edge JA; Dunger DB
    Diabetes Res; 1993; 22(2):59-65. PubMed ID: 8205738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical consequences of intranasal insulin therapy in insulin-dependent diabetes mellitus].
    Hilsted JC; Madsbad S; Rasmussen MH; Hvidberg A; Krarup T; Ipsen H; Hansen B; Pedersen M; Djurup R; Oxenbøll B
    Ugeskr Laeger; 1996 Jun; 158(24):3451-5. PubMed ID: 8650814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.
    Rosenstock J; Park G; Zimmerman J;
    Diabetes Care; 2000 Aug; 23(8):1137-42. PubMed ID: 10937511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixtures of soluble insulin with zinc-suspension or protamine insulin have different effect on blood glucose and free insulin levels in insulin dependent diabetes.
    Lunetta M; Di Mauro M; Mughini L
    Diabete Metab; 1988; 14(3):315-6. PubMed ID: 3044867
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of insulin concentration on bioavailability during nasal spray administration.
    Valensi P; Zirinis P; Nicolas P; Perret G; Sandre-Banon D; Attali JR
    Pathol Biol (Paris); 1996 Apr; 44(4):235-40. PubMed ID: 8763584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple daily insulin injections: a multicentre study on acceptability and efficacy.
    Houtzagers CM; van der Velde EA
    Neth J Med; 1988 Aug; 33(1-2):16-25. PubMed ID: 3073315
    [No Abstract]   [Full Text] [Related]  

  • 20. Guidelines for premeal insulin dose reduction for postprandial exercise of different intensities and durations in type 1 diabetic subjects treated intensively with a basal-bolus insulin regimen (ultralente-lispro).
    Rabasa-Lhoret R; Bourque J; Ducros F; Chiasson JL
    Diabetes Care; 2001 Apr; 24(4):625-30. PubMed ID: 11315820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.